Oppenheimer Asset Management’s Sanofi SNY Stock Holding History

Oppenheimer Asset Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.29M	Sell	217,874 -18,634	-8%	-$833K	0.1%	237
2026 Q1	$11.4M	Buy	236,508 +51,487	+28%	+$2.4M	0.13%	182
2025 Q4	$8.97M	Buy	185,021 +5,812	+3%	+$288K	0.11%	211
2025 Q3	$8.46M	Buy	179,209 +11,965	+7%	+$577K	0.09%	239
2025 Q2	$8.08M	Buy	167,244 +11,864	+8%	+$606K	0.09%	240
2025 Q1	$8.62M	Buy	155,380 +28,569	+23%	+$1.55M	0.11%	216
2024 Q4	$6.12M	Buy	126,811 +1,216	+1%	+$61.8K	0.07%	282
2024 Q3	$7.24M	Sell	125,595 -10,156	-7%	-$548K	0.09%	243
2024 Q2	$6.59M	Buy	135,751 +14,455	+12%	+$697K	0.08%	259
2024 Q1	$5.89M	Sell	121,296 -19,429	-14%	-$949K	0.09%	256
2023 Q4	$7M	Sell	140,725 -22,197	-14%	-$1.09M	0.1%	237
2023 Q3	$8.74M	Buy	162,922 +1,048	+0.6%	+$55.9K	0.13%	182
2023 Q2	$8.73M	Sell	161,874 -310	-0.2%	-$16.7K	0.13%	191
2023 Q1	$8.83M	Buy	162,184 +22,592	+16%	+$1.1M	0.14%	181
2022 Q4	$6.76M	Sell	139,592 -12,517	-8%	-$549K	0.11%	219
2022 Q3	$5.78M	Sell	152,109 -50,688	-25%	-$2.26M	0.1%	230
2022 Q2	$10.1M	Sell	202,797 -22,576	-10%	-$1.2M	0.17%	146
2022 Q1	$11.6M	Buy	225,373 +3,811	+2%	+$197K	0.16%	152
2021 Q4	$11.1M	Sell	221,562 -11,910	-5%	-$589K	0.15%	162
2021 Q3	$11.3M	Sell	233,472 -1,576	-0.7%	-$80.1K	0.16%	150
2021 Q2	$12.4M	Buy	235,048 +2,947	+1%	+$154K	0.18%	134
2021 Q1	$11.5M	Buy	232,101 +30,974	+15%	+$1.49M	0.18%	139
2020 Q4	$9.77M	Buy	201,127 +14,399	+8%	+$710K	0.16%	161
2020 Q3	$9.37M	Buy	186,728 +24,932	+15%	+$1.28M	0.18%	144
2020 Q2	$8.26M	Buy	161,796 +6,127	+4%	+$298K	0.17%	148
2020 Q1	$6.81M	Sell	155,669 -8,776	-5%	-$420K	0.17%	148
2019 Q4	$8.26M	Buy	164,445 +22,687	+16%	+$1.06M	0.17%	149
2019 Q3	$6.57M	Sell	141,758 -10,907	-7%	-$470K	0.15%	173
2019 Q2	$6.61M	Sell	152,665 -14	-0%	-$595	0.15%	179
2019 Q1	$6.76M	Sell	152,679 -10,749	-7%	-$460K	0.15%	171
2018 Q4	$7.1M	Sell	163,428 -26,857	-14%	-$1.18M	0.18%	136
2018 Q3	$8.5M	Sell	190,285 -959	-0.5%	-$41K	0.19%	136
2018 Q2	$7.65M	Buy	191,244 +3,065	+2%	+$121K	0.19%	138
2018 Q1	$7.54M	Buy	188,179 +33,702	+22%	+$1.4M	0.19%	133
2017 Q4	$7.69M	Hold	154,477	–	–	0.2%	127
2017 Q3	$7.69M	Sell	154,477 -3,125	-2%	-$151K	0.2%	129
2017 Q2	$7.55M	Sell	157,602 -10,787	-6%	-$516K	0.21%	128
2017 Q1	$7.62M	Buy	+168,389	New	+$7.14M	0.22%	112

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Oppenheimer Asset Management's SNY Position: Q2 2026 in Review

Oppenheimer Asset Management reduced its Sanofi (SNY) stake by 7.9% in Q2 2026, selling an estimated $833K and leaving 217,874 shares worth $9.29M. The position accounts for 0.1% of the portfolio, ranked #237.

Oppenheimer Asset Management first reported a position in SNY in Q1 2017 and has held it in 38 quarters since. The position peaked at $12.4M in Q2 2021. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Oppenheimer Asset Management held 217,874 shares of Sanofi worth $9.29M as of Q2 2026.
Oppenheimer Asset Management sold 18,634 Sanofi shares in Q2 2026, an estimated $833K.
Sanofi made up 0.1% of Oppenheimer Asset Management's portfolio in Q2 2026, its #237 holding.
Oppenheimer Asset Management first reported a position in Sanofi in Q1 2017 and has held it in 38 quarters since.
Oppenheimer Asset Management's Sanofi position peaked at $12.4M in Q2 2021.
718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Oppenheimer Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.